Temefos

Temefos

SCHEMBL6388031

COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1.[CaH2]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
ALDH1A1 P00352 3/20 0.51
CYP3A4 P08684 3/20 0.51
HSD17B10 Q99714 3/20 0.51
MAPK1 P28482 2/20 0.51
THRB P10828 2/20 0.51
TP53 P04637 1/20 0.51
TSHR P16473 2/20 0.49
PTGIR P43119 4/20 0.37
STS P08842 4/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HAO1 Q9UJM8 1/20 0.32
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Temefos SCHEMBL23303378 0.98 LMNA (0.53) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL44105 0.98 LMNA (0.53) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL8741692 0.96 LMNA (0.51) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL10455340 0.91 LMNA (0.47) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL15553439 0.91 LMNA (0.51) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
SCHEMBL30412917 0.86 CYP3A4 (0.53) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL9193178 0.85 LMNA (0.54) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
SCHEMBL11061618 0.84 ALDH1A1 (0.57) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL9809762 0.84 LMNA (0.42) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL20919592 0.84 ALDH1A1 (0.46) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506252-A1 HOME CARE COMPOSITIONS COMPRISING A DICARBOXY FUNCTIONALIZED POLYORGANOSILOXANE The Procter & Gamble Company (US) 2005-02-16 EP disclosed
WO-2003095530-A1 HOME CARE COMPOSITIONS COMPRISING A DICARBOXY FUNCTIONALIZED POLYORGANOSILOXANE THE PROCTER & GAMBLE COMPANY (US) 2003-11-20 WO disclosed